U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.

Shares of Acuity Brands, Inc. AYI rose sharply Tuesday’s session after the company reported better-than-expected first-quarter earnings.

Acuity Brands reported a first-quarter FY24 net sales decline of 9% year-over-year to $934.7 million, marginally missing the consensus of $935.1 million. Adjusted EPS of $3.72 beat the consensus of $3.23.

Acuity Brands shares jumped 10.2% to $225.51 on Tuesday.

Here are some other big stocks recording gains in today’s session.

  • Juniper Networks, Inc. JNPR shares gained 21.5% to $36.71. Hewlett Packard Enterprise Co HPE is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks.
  • Accolade, Inc. ACCD jumped 17.2% to $13.61 following third-quarter results.
  • Century Aluminum Company CENX shares rose 14.4% to $12.18. B. Riley Securities upgraded Century Aluminum from Neutral to Buy and raised the price target from $10 to $14.
  • ACM Research, Inc. ACMR surged 12.8% to $19.22. ACM Research said it sees FY23 revenue of $530 million to $545 million.
  • Recursion Pharmaceuticals, Inc. RXRX gained 10.9% to $13.98.
  • Nukkleus Inc. NUKK gained 9.6% to $2.27.
  • Wheels Up Experience Inc. UP jumped 9.6% to $4.66.
  • Urban Outfitters, Inc. URBN climbed 9.1% to $39.17 after the company reported a 10% increase in total company net sales for the two months ended Dec. 31, 2023.
  • Sotera Health Company SHC rose 9.1% to $17.22. Sotera Health presented FY23 revenue guidance of $1.04 billion to $1.05 billion at 42nd Annual J.P. Morgan Healthcare Conference.
  • NextNav Inc. NN gained 9% to $5.04.
  • MaxCyte, Inc. MXCT rose 8.9% to $5.00 after the company announced strong preliminary fourth-quarter and full year 2023 revenue results.
  • IGM Biosciences, Inc. IGMS gained 8.5% to $12.04.
  • Orthofix Medical Inc. OFIX gained 8.4% to $14.40. Orthofix Medical reported preliminary FY23 net sales of $746.3 million versus consensus of $741.52 million.
  • Establishment Labs Holdings Inc. ESTA rose 8.4% to $29.95. Establishment Labs announced a $50 Million private placement and preliminary unaudited financial results for the fourth quarter and fiscal year 2023.
  • Illumina, Inc. ILMN gained 8.2% to $144.72 after the company reported preliminary FY23 consolidated revenue guidance above estimates.
  • Sarepta Therapeutics, Inc. SRPT gained 6.6% to $109.40. Wedbush analyst Andreas Argyrides reiterated Sarepta Therapeutics with an Outperform and maintained a $224 price target.

 

Now Read This: Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!